8-K
Current Report
Vaxart, Inc. Filed Acc 0001437749-13-015134
Exit or restructuring costs
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading bota20131121_8k.htm…